Evidence map›Paper›PMID 1384267›Full record

ArticleActa neuropathologica1992

The fate of desmin and titin during the degeneration and regeneration of the soleus muscle of the rat.

R Vater, M J Cullen, J B Harris

Abstract read
PubMed Publisher
In one paragraph

Article in Acta neuropathologica, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Diagnostic protein expression in human muscle biopsies.Brain pathology (Zurich, Switzerland) · 2000
    Review
  8. Article
  9. Activation of the skeletal alpha-actin promoter during muscle regeneration.Journal of muscle research and cell motility · 1998
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

R VaterMuscular Dystrophy Group Research Laboratories, Newcastle General Hospital, Newcastle-upon-Tyne, UK.
M J Cullen
J B Harris
North Tyneside General Hospital · GBMuscular Dystrophy UK · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

We studied the fate of desmin and titin in rat skeletal muscle during a cycle of degeneration and regeneration induced in vivo by the inoculation of a snake venom. Cryosections of muscle were labelled using antibodies to the two proteins, and examined at fixed time points after venom injection. Early pathological changes in the muscle, such as hypercontraction, preceded the loss of desmin. Immunolabelling using anti-desmin antibodies showed that desmin bridges were still intact when adjacent myofibrils were no longer aligned. The results suggested that although the hydrolysis of desmin is not necessary for the hypercontraction of muscle fibres, it probably contributes to complete fibre breakdown. Titin, or at least the part which lies close to the M-line, remained intact longer than desmin, but was also hydrolysed prior to complete disintegration of the fibres. Both desmin and titin were re-expressed in the regenerating myotubes by 2 days after venom inoculation, and became well organised even before the myofibrils became aligned. We conclude that desmin and titin are involved in both establishing and maintaining the structural integrity of the muscle fibres.

Indexed as

Protein KinasesAnimalsBlotting, WesternConnectinDesminFemaleImmunohistochemistryMuscle ProteinsMusclesRatsRats, WistarRegenerationSnake VenomsStaining and LabelingConnectinDesminMuscle ProteinsProtein KinasesSnake Venoms

Identifiers

PMID1384267
OpenAlexW1964473203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.